How to Treat ADHD in Bipolar Disorder

Topics: ADHD | Alpha Agonists | Amphetamines | ArModafinil | Atomoxetine | Attention Deficit Hyperactivity Disorder | Bipolar Disorder | Bipolar II | Comorbidity | Guanfacine | methylphenidate | Modafinil | Nuvigil | Pharmacology | Provigil | Psychopharmacology | Psychopharmacology Tips | stimulant | Stimulants

Patients with bipolar disorder often present with cognitive complaints. Our October 2021 issue laid out a diagnostic plan for these symptoms, and in this article, I’ll cover some treatment approaches for patients with a DSM-based ADHD-bipolar comorbidity (ie, the ADHD symptoms began in childhood and persist after the mood episodes have stabilized).

Viloxazine for ADHD

Topics: ADHD | Atomoxetine | Attention Deficit Hyperactivity Disorder | Qelbree | Research Update | Viloxazine

Review of: Nasser A et al, Int J Clin Pract 2021;75(8):e14330 Study type: Meta-analysis of randomized controlled trials Viloxazine (Qelbree) just got FDA approval in 2021 for the treatment of ADHD in children and adolescents, and the FDA is reviewing data in adult ADHD. Viloxazine has a long history of use as an antidepressant in Europe. Like atomoxet

Atomoxetine: Myths and Truths

Topics: ADHD | Atomoxetine | stimulant | Stimulants

Atomoxetine (Strattera) is approved for ADHD in children and adults but has also been explored in many other disorders. That has led to some myths and truths that we’ll explore here. First, a little about atomoxetine’s mechanism of action. Atomoxetine is a selective norepinephrine reuptake inhibitor, a mechanism shared by maprotiline, a long-forg